Decera Clinical Education Infectious Disease Podcast

Achieving virologic suppression is still the primary goal of HIV management, but treatment individualization and optimization should be equally prioritized. There are many reasons to consider switching a suppressive ART regimen that have nothing to do with resistance or treatment failure, including newly approved regimens, personal preference, changes in comorbidities or coinfections, and quality of life. Listen in to learn practical strategies for proactive ART switch, and learn how to guide clinical conversations about ART switch in this podcast, featuring audio from a live webinar hosted by National Clinician Consultation Center experts Daniel Moring-Parris, MD, AAHIVS and Cristina Gruta, PharmD, AAHIVP. For more, visit the program page on our website.
Presenters:
Daniel Moring-Parris, MD, AAHIVS
Family Medicine Clinician and HIV Specialist, Contra Costa Health
Co-Director, HIV Track, Contra Costa Family Medicine Residency
Consultant, UCSF National Clinician Consultation Center
Martinez, California
Cristina Gruta, PharmD, AAHIVP
Principal HIV/HCV Clinical Education Pharmacy Specialist
National Clinician Consultation Center
Clinical Pharmacist
UCSF 360 Positive Care Clinic
Assistant Clinical Professor
UCSF School of Pharmacy (WOS)
San Francisco, California
Link to program page:
https://bit.ly/4ywDm5Z
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, featuring audio from a live webinar, experts Claudia P. Cortes, MD, and Chloe Orkin, MBChB, FRCP, MD, explore advancements in HIV prevention and treatment presented at the 26th International AIDS Conference (AIDS 2026). To download the accompanying slides and view more conference coverage, visit the program page.

Topics covered include:

New clinical trial and real-world data for available and emerging initial antiretroviral therapy (ART) regimens for people living with HIV

Long-acting options for ART and HIV pre-exposure prophylaxis (PrEP).

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:
Claudia P. Cortes, MD

Full Professor

Director for Centre for HIV AIDS Integral Research – CHAIR

Universidad De Chile

Santiago, Chile

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities

Dean for Healthcare Transformation

Faculty of Medicine and Dentistry

Queen Mary University of London

Honorary Consultant Physician, Barts Health NHS Trust

London, United Kingdom

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Vaccine-preventable diseases have resurged despite decades of successful mitigation, due in part to changing vaccine recommendations. Featuring audio from a live webinar with experts Paul G. Auwaerter, MD, MBA, FIDSA, FACP, and Camille Nelson Kotton, MD, FIDSA, FAST, this podcast explores current events in vaccines and their implications on patient vaccine uncertainty, with expert discussion of learner-submitted questions. For more, and to download the accompanying slides, visit our program page. Topics covered include:

Current Outbreaks of Vaccine-Preventable Diseases

Changes in Current Federal HHS/CDC Vaccine Recommendations

Resources to Consult for Vaccine Recommendations

The Vaccine Hesitancy Continuum

Shared Clinical Decision-making

Memorable Messaging Tools

Presenters:

Paul G. Auwaerter, MD, MBA

Sherrilyn and Ken Fisher Professor of Medicine

Divisions of Infectious Diseases and General Internal Medicine

Johns Hopkins University School of Medicine

Baltimore, Maryland

Camille Nelson Kotton, MD, FIDSA, FAST

Clinical Director, Transplant and Immunocompromised Host Infectious Diseases

Infectious Diseases Division

Massachusetts General Hospital

Associate Professor, Harvard Medical School

Boston, Massachusetts

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Same-day PrEP decreases barriers to PrEP uptake, minimizes the number of people lost at early points in the care continuum, and accelerates the onset of protection. Tune in to this podcast featuring highlights from a live webinar to learn how rapid-start PrEP can take your practice from zero to protected with experts Kenneth H. Mayer, MD and Sarah E. Rowan, MD, FIDSA. For more activities on this topic and to download the accompanying slides, visit the program page.

Topics covered in this podcast include:

Supporting Evidence for Same-Day Prep

Recommended Testing and Monitoring

PrEP Options for Same-Day Initiation

Recommendations for Implementation in Varied Practice Settings

nPEP as an Option for Same-Day PrEP

Considerations for Paying for PrEP

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Kenneth H. Mayer, MD

Medical Researcher Director

Fenway Health

Co-Director

The Fenway Institute

Professor of Medicine

Harvard Medical School

Attending Physician

Infectious Disease Division

Beth Israel Deaconess Hospital

Boston, Massachusetts

Sarah E. Rowan, MD

Director, Division of Sexual Health, HIV, and Viral Hepatitis

Public Health Institute at Denver Health

Medical Director, Denver Prevention Training Center

Associate Director, Mentored Scholarly Activity Program

Associate Professor of Medicine

Division of Infectious Diseases

University of Colorado

School of Medicine

Denver, Colorado

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Currently, annual influenza vaccination is recommended for everyone 6 months of age or older who do not have a contraindication, but vaccine uptake was suboptimal among adults and children during the most recent season. In anticipation of influenza season, tune into to this podcast featuring audio from a live webinar to listen as experts Mary Barna Bridgeman, PharmD, BCPS, BCGP, and Jana Shaw, MD, MPH, MS, FAAP, FPIDS, discuss the 2025-2026 influenza season and explore strategies to improve your confidence in optimizing influenza vaccine uptake for pediatric and adult patients. To download the accompanying slides, and view additional activities, visit the program page.

Topics covered in this podcast include:

Influenza Uptake and Viral Activity During the 2025-2026 Season

Influenza Vaccine Selection

The Influenza Vaccine Dosing Algorithm for Children Aged 6 Months Through 8 Years

Comparative Analysis of Immune Response to Seasonal Inactivated Influenza Vaccines

Preferential Recommendations for Older Adults

Strategies to Improve Outcomes for the 2026-2027 Season

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Presenters:

Mary Barna Bridgeman, PharmD, BCPS, BCGP

Clinical Professor

Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey

Piscataway, New Jersey

Internal Medicine Clinical Pharmacy Specialist

Robert Wood Johnson University Hospital-New Brunswick

New Brunswick, New Jersey

Jana Shaw, MD, MPH, MS, FAAP, FPIDS

Professor of Pediatrics, Public Health, and Preventive Medicine

Pediatric Infectious Diseases

Hospital Epidemiologist, Upstate Golisano Children’s Hospital

SUNY Upstate Medical University

Syracuse, New York

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.